Peptide-Nucleic Acids TRIZ Cases

Hydrocarbon staples enhance protease resistance and binding affinity, resolving peptide degradation trade-offs.

Intramolecular bridges in modified oxyntomodulin analogues resist enzymatic degradation, extending half-life to reduce injection frequency.

Triblock peptide amphiphiles form stable micelles that enable room temperature storage and improved safety by eliminating pathogen reversion risks.

A synthetic peptide with a polyserine core and kinase docking site dissolves tau inclusions through targeted phosphorylation.

Merging three peptide strands into one chain eliminates concentration dependence and prevents undesired homo-oligomer formation.

A pH-triggered polypeptide conjugated to a fluorophore enables real-time cancer tissue imaging.

Transforms cysteine to serine via methylation and cyanation, enabling ligation of peptides lacking native cysteine.

Charge-complementary peptides self-assemble into stable nanoparticles, overcoming aggregation issues during protein expression.

High density brush polymers package peptides via ring-opening metathesis polymerization to shield biological molecules.

Peptide disrupts p53-FOXO4 binding to selectively eliminate senescent cells, reducing side effects from conventional antioxidant drugs.

LAH4 peptides increase viral transduction efficiency by bypassing complex purification protocols required for high-titer lentiviral vectors.

Leucine mutations at position 23 in ankyrin repeat domains improve thermostability and refolding properties by strengthening internal structural interactions.

Segmenting the 39-amino acid chain into fragments and applying orthogonal protecting groups prevents side reactions, achieving purity above 99.0%.

Self-assembling peptides form localized barriers at inflammation sites to reduce symptoms without systemic side effects.

Novel polypeptide scaffold with targeted amino acid substitutions increases structural stability and shelf-life while preserving target binding capacity.

Developing PAC1 receptor antagonist peptides resolves the contradiction between therapeutic effectiveness and patient tolerability in migraine treatment.

Positively charged ClyA nanopores overcome electrostatic barriers to enable efficient DNA translocation at low ionic strengths.

Modified peptide sequence binds iridium nanoparticles, resolving insufficient recognition of existing peptides.

Novel antimicrobial peptides with specific amino acid sequences target bacterial membranes through electrostatic interactions.

Fmoc solid-phase synthesis achieves 99% purity and 63% yield, resolving the contradiction between manufacturing precision and productivity.